The VACCINES Act: Deciphering Vaccine Hesitancy in the Time of COVID-19.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 32282038.
- Also identified by DOI 10.1093/cid/ciaa433 and PMC identifier 7184475.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Since the COVID-19 pandemic first hit Wuhan, China, in December 2019, scientists have been racing to develop and test novel vaccines to protect against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The speed of scientific discovery related to COVID-19 is unprecedented. With several vaccine candidates already being tested in clinical trials, we pose the question: what will the vaccine hesitant do in the face of this pandemic?
Medical subject headings
- Betacoronavirus
- Coronavirus Infections
- Immunization Programs
- Legislation, Drug
- Pandemics
- Pneumonia, Viral
- Vaccination Refusal
- Viral Vaccines